Starla J Swaim, PharmD, BCOP, currently serves as Director, Medical Science Liaison - Immunology at argenx since April 2024. Prior experience includes a role as Medical Science Liaison at PharmaEssentia from February 2021 to March 2024, where Starla successfully contributed to the launch of Ropeginterferon (BESREMi) and produced analytical reports for the MSL team while fostering relationships with key opinion leaders. At Jazz Pharmaceuticals, from September 2018 to February 2021, Starla held the position of Sr. Hematology/Oncology Medical Science Liaison, supporting products related to hematologic malignancies and engaging in scientific exchanges. Prior to this, Starla worked as a Clinical Pharmacy Specialist in Leukemia at MD Anderson Cancer Center from July 2007 to August 2018, providing clinical services in both inpatient and outpatient settings. Starla completed PGY-2 Oncology Practice and PGY-1 Pharmacy Practice residencies at UC Health and began a career as a Pharmacy Intern at Walgreens from 1997 to 2005. The educational background includes a Doctor of Pharmacy (PharmD) degree from The University of Kansas, obtained between 1999 and 2005.
This person is not in any teams
This person is not in any offices